This HTML5 document contains 57 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73628374
rdf:type
wikibase:Item
schema:description
scientific article published on 01 July 2003 article scientifique publié en 2003 wetenschappelijk artikel im Juli 2003 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в липні 2003 artículu científicu espublizáu en xunetu de 2003
p:P577
wds:Q73628374-18EDFFDE-A228-4A4F-9F11-3BC4BB5AC4C9
wdt:P577
2003-07-01T00:00:00Z
p:P2093
wds:Q73628374-D8FE7CA2-F089-4A5C-8F6E-41348F659DDB wds:Q73628374-9D6944AD-2DF6-4EB7-88BA-22B577576375 wds:Q73628374-B7175FCA-40A4-49CD-A0E1-74E0BD8C9B14 wds:Q73628374-8DC69E5E-0607-42E0-B2B0-13340D61E903 wds:Q73628374-83196029-5352-4C50-A032-61EBF948F203 wds:Q73628374-78A0CF23-DD0E-4F6D-AF2A-7D6793180A53 wds:Q73628374-5F686791-64D2-414D-9730-726A4688FE6E wds:Q73628374-1C7E09F4-4942-46B6-8802-98BA743084BE wds:Q73628374-231740F1-F021-4FC0-99FF-6B01673701F7
wdt:P2093
Jacques-Eric Gottenberg Francis Berenbaum Antoine Durbach Jean Sibilia Fabrice Bentaberry Yannick Allanore Maxime Dougados Bruno Fautrel Florence Merle-Vincent
rdfs:label
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy
skos:prefLabel
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy
schema:name
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy
p:P50
wds:Q73628374-044F8D13-34AE-46A2-B394-0545A3596B46 wds:Q73628374-103B9148-B797-45BB-9F94-8F94D26328FB
wdt:P50
wd:Q93104907 wd:Q92771497
p:P1476
wds:Q73628374-CF4C916A-CA65-458D-8182-0029EDD63983
wdt:P1476
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy
p:P304
wds:Q73628374-6CC5D333-DF95-462B-B300-54E0D7B2D733
wdt:P304
2019-2024
p:P31
wds:Q73628374-91CB5810-1E91-40E3-A2F2-F1FECEF449F4
wdt:P31
wd:Q13442814
p:P921
wds:Q73628374-7E61E3A9-AC66-4556-9BEF-5F5D21325691
wdt:P921
wd:Q2844591
p:P698
wds:Q73628374-C090A235-C953-4409-8780-D298C9F53C65
wdtn:P698
n10:12847696
wdt:P698
12847696
p:P1433
wds:Q73628374-C69BFBE0-2FA3-46C2-BB0A-4D1DAB9E0620
wdt:P1433
wd:Q23929027
p:P433
wds:Q73628374-BFBEE082-E327-426F-951F-B6F56EE71077
p:P478
wds:Q73628374-65BA3514-34AC-4124-B987-B74FF312F9E8
wdt:P433
7
wdt:P478
48
p:P356
wds:Q73628374-FF0AA7D9-C814-4F8A-8B05-A6D205351236
wdtn:P356
n11:ART.11163
wdt:P356
10.1002/ART.11163